IRIS
PICARDI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 14.898
NA - Nord America 6.911
EU - Europa 2.254
SA - Sud America 796
AF - Africa 110
Continente sconosciuto - Info sul continente non disponibili 79
OC - Oceania 30
Totale 25.078
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 11.048
US - Stati Uniti d'America 6.591
CN - Cina 1.633
IT - Italia 1.089
HK - Hong Kong 966
BR - Brasile 508
BD - Bangladesh 373
VN - Vietnam 325
GB - Regno Unito 322
FR - Francia 264
DE - Germania 173
CA - Canada 147
IN - India 122
AR - Argentina 87
MX - Messico 84
ID - Indonesia 68
FI - Finlandia 60
NL - Olanda 58
EC - Ecuador 57
TR - Turchia 54
CO - Colombia 53
PL - Polonia 42
ES - Italia 38
RU - Federazione Russa 38
ZA - Sudafrica 38
UA - Ucraina 36
MY - Malesia 32
PH - Filippine 32
VE - Venezuela 32
SA - Arabia Saudita 29
AU - Australia 27
PK - Pakistan 26
CZ - Repubblica Ceca 25
IQ - Iraq 23
JP - Giappone 23
CL - Cile 20
JM - Giamaica 17
HN - Honduras 14
CH - Svizzera 13
CR - Costa Rica 13
NP - Nepal 12
PY - Paraguay 12
SE - Svezia 12
AE - Emirati Arabi Uniti 11
MA - Marocco 11
PE - Perù 11
UZ - Uzbekistan 10
IE - Irlanda 9
TH - Thailandia 9
BH - Bahrain 8
BO - Bolivia 8
EG - Egitto 8
TT - Trinidad e Tobago 8
AL - Albania 7
AZ - Azerbaigian 7
BE - Belgio 7
DK - Danimarca 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
IL - Israele 7
JO - Giordania 7
LT - Lituania 7
NI - Nicaragua 7
OM - Oman 7
SY - Repubblica araba siriana 7
UY - Uruguay 7
AM - Armenia 6
AT - Austria 6
GT - Guatemala 6
KZ - Kazakistan 6
LB - Libano 6
BY - Bielorussia 5
KE - Kenya 5
KR - Corea 5
TN - Tunisia 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
CY - Cipro 4
EE - Estonia 4
ET - Etiopia 4
HU - Ungheria 4
IR - Iran 4
MD - Moldavia 4
MN - Mongolia 4
SV - El Salvador 4
XK - ???statistics.table.value.countryCode.XK??? 4
BG - Bulgaria 3
BS - Bahamas 3
CI - Costa d'Avorio 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
RS - Serbia 3
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HT - Haiti 2
IS - Islanda 2
KW - Kuwait 2
Totale 24.948
Salva come PNG Salva come JPEG
Città #
Ashburn 1.482
San Jose 1.456
Singapore 1.055
Hong Kong 944
Rome 705
Hefei 495
Beijing 406
Council Bluffs 326
Boardman 265
Columbus 257
Dallas 248
Lauterbourg 221
London 207
Shanghai 195
Santa Clara 171
Phoenix 159
Ho Chi Minh City 123
Los Angeles 104
New York 96
Munich 87
San Francisco 66
Hanoi 61
São Paulo 54
Mexico City 53
Toronto 47
Seattle 44
West Jordan 41
Buffalo 38
Turku 38
Warsaw 37
Washington 35
Amsterdam 34
Pune 32
Brasília 30
Milan 30
Montreal 28
Atlanta 25
Rio de Janeiro 25
Brooklyn 24
Brno 22
Chennai 22
Helsinki 22
Naples 22
Chicago 21
Denver 21
Orem 21
Bogotá 20
Guayaquil 20
Sona 20
Guangzhou 19
Manchester 19
Boston 18
Charlotte 18
Haiphong 18
Quito 18
Tokyo 18
Johannesburg 17
Las Vegas 17
Frankfurt am Main 16
Kuala Lumpur 15
Houston 14
Paris 14
Lahore 13
Riyadh 13
Bologna 12
Da Nang 12
Melbourne 12
Miami 12
Central 11
Bari 10
Istanbul 10
San José 10
Stockholm 10
Tashkent 10
The Dalles 10
Thái Bình 10
Canberra 9
Curitiba 9
Genoa 9
Kingston 9
Queens 9
Buenos Aires 8
Hangzhou 8
Jeddah 8
Moscow 8
Mumbai 8
New Delhi 8
Richmond 8
Zhengzhou 8
Belo Horizonte 7
Brescia 7
Dublin 7
Kyiv 7
Medellín 7
Pasadena 7
Philadelphia 7
Redmond 7
Turin 7
Verona 7
Amman 6
Totale 10.516
Salva come PNG Salva come JPEG
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 271
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 264
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 263
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 259
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 257
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 254
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 245
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 244
[Protective effect of verapamil in myocardial hypertrophy due to aortic stenosis experimentally induced in the rat] 243
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 241
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 240
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 240
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 240
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 237
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 236
[Consensus interferon: a new weapon in the treatment of chronic hepatitis C] 232
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 231
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 230
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 230
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 229
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 228
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 223
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 223
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 222
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 222
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 221
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 216
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 215
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 214
Blood glucose monitoring in the normal population: the PREDICA study 213
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 212
Assessment of liver function by the exhaled breath-print during chronic liver disease 210
ALEX (R) (artificial liver for extracorporeal xenoassistance): A new bioreactor containing a porcine autologous biomatrix as hepatocyte support. Preliminary results in an ex vivo experimental model 208
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 206
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 204
[Hepatocarcinoma: from epidemiology to gene therapy] 203
Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon 203
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 182
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 181
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 178
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 164
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 163
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 156
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 151
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 151
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 149
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 147
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 144
Anestesia e malattie non comuni 144
Effectiveness of group medical nutrition therapy in lowering HbA(1c) in type 2 diabetes 144
Diabetes in chronic liver disease: from old concepts to new evidence 143
GH-resistance in different stages of chronic liver disease 142
[A 73-year-old woman with vomiting and metabolic alkalosis] 142
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 141
[A 74-year-old woman with macrocytic anemia] 141
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 140
Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I 139
A challenging alfa-fetoprotein in a cirrhotic patient 139
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 136
A potential experimental model for the study of osteopenia in CCl4 liver cirrhotic rats 135
[A 61-year-old woman with abdominal pain and urination disorders] 134
Enhanced portal flow velocity and volume following Iloprost treatment 134
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 133
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 131
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 131
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 130
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 129
Radiofrequency ablation of hepatic tissue: a new experimental animal model 126
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 125
Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support 125
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 124
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 122
Anesthesia & uncommon diseases 122
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 122
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 121
Breathprinting of liver diseases 120
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 119
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 118
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 118
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 118
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 117
Pain and Frailty in Hospitalized Older Adults 114
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies: Haploidentical vs HLA Identical Transplantation in Hematologic Malignancies 114
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 113
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 112
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 109
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 107
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 105
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 103
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 101
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 100
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 99
Lipophagy Impairment Is Associated With Disease Progression in NAFLD 99
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 99
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 98
Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study 98
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 97
The PREDICA study (PREdiction of diabetes from CApillary Blood Glucose) in the general population 95
The role of S-adenosylmethionine in preventing oxaliplatin-induced liver toxicity: a retrospective analysis in metastatic colorectal cancer patients treated with bevacizumab plus oxaliplatin-based regimen 94
TNF-alpha and growth hormone resistance in patients with chronic liver disease 93
Totale 16.550
Salva come PNG Salva come JPEG
Categoria #
all - tutte 143.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.621
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022383 0 0 0 0 3 3 4 5 35 10 5 318
2022/2023118 21 1 3 5 5 5 15 4 3 8 45 3
2023/2024824 51 54 25 78 77 333 3 37 13 76 28 49
2024/202512.233 146 74 306 50 192 279 163 39 646 801 4.413 5.124
2025/20268.685 773 390 548 874 357 477 2.246 517 652 769 613 469
2026/20272.824 150 907 1.115 652 0 0 0 0 0 0 0 0
Totale 25.078